Search

In this study, modified sol-gel method was employed to synthesize the pure and Zr-doped titania catalysts. Brunauer-Emmett-Teller (BET) method was applied to determine porosity, X-ray diffraction (XRD) analysis was used to study crystal structure, scanning electron microscopy (SEM) was used to investigate morphology and Fourier transform infrared spectroscopy (FTIR) was used to examine surface properties/total acidity of the obtained catalysts samples. Photocatalytic activity was tested in the reaction of crystal violet (CV) dye decolourization/degradation under UV light irradiation. The effects of several photocatalysis operational parameters were considered, such as catalyst dosage, initial dye concentrations, duration of UV irradiation treatment, as well as catalysts calcination temperatures and dopant amounts. The obtained results indicated faster dye decolourization/degradation with the increase of the catalyst dosage and the decrease of initial CV concentrations. The Zr-doping affects photocatalytic properties, i.e. CV decolourization/degradation of the prepared catalytic materials. Thus, addition of 5 wt.% of ZrO2 to titania increases photocatalytic effect for ∼15% and addition of 10 wt.% of ZrO2 improves the photocatalytic efficiency of titania for nearly 30%.

A high-performance liquid chromatography (HPLC) system was used in the reversed phase mode for the determination of benzalkonium chloride (BKC) in nosal drops. A Chromolit RP-18e, 100 x 4.6, (UM6077/035) column was used at 40 °C. The mobile phase, optimized through an experimental design, was a 70:30 (v/v) mixture of 0.057M Na-heksansulphonate potassium, dihydrogen orthophosphate buffer (pH 2.9) and acetonitrile, pumped at a flow rate of 1.75 mL/min at maintaining column temperature at 40 °C. Maximum UV detection was achieved at 215 nm. The method was validated in terms of selectivity, linearity, repeatability, precision and accuracy. The method was successfully applied for the determination of BKC in a pharmaceutical formulation of nasal drop solution without any interference from common excipients and drug substance. All the validation parameters were within the acceptance range, concordant to ICH guidelines.